Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring
American Journal of Clinical and Experimental Immunology · 2025
DOI: 10.62347/ebry4326 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2025. Verfasst von Wanyu Dong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematological Laboratory Science, Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu Univer…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematological Laboratory Science, Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University Zhenjiang 212013, Jiangsu, China.
- Shenzhen International Institute for Biomedical Research Shenzhen 518110, Guangdong, China.
- Shenzhen Walgenron Bio-Pharm Co., Ltd. Shenzhen 518118, Guangdong, China.
- The Molecular Oncology Laboratory, Department of Orthopaedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center Chicago, IL 60637, USA.
Zitieren
APA
Dong, W., Hu, W., Lu, Y., & Zheng, Q. (2025). Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring. American Journal of Clinical and Experimental Immunology. https://doi.org/10.62347/ebry4326
Vancouver
Dong W, Hu W, Lu Y, Zheng Q. Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring. American Journal of Clinical and Experimental Immunology. 2025. doi:10.62347/ebry4326
BibTeX
@article{Dong2025,
author = {Dong, Wanyu and Hu, Wenshi and Lu, Yaojuan and Zheng, Qiping},
title = {Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring},
journal = {American Journal of Clinical and Experimental Immunology},
year = {2025},
doi = {10.62347/ebry4326}
}
EUVIMED